Literature DB >> 19428380

Quantitative PCR analysis of diepoxybutane and epihalohydrin damage to nuclear versus mitochondrial DNA.

Frederick J Lariviere1, Adam G Newman, Megan L Watts, Sharonda Q Bradley, Justin E Juskewitch, Paul G Greenwood, Julie T Millard.   

Abstract

The bifunctional alkylating agents diepoxybutane (DEB) and epichlorohydrin (ECH) are linked to the elevated incidence of certain cancers among workers in the synthetic polymer industry. Both compounds form interstrand cross-links within duplex DNA, an activity suggested to contribute to their cytotoxicity. To assess the DNA targeting of these compounds in vivo, we assayed for damage within chicken erythro-progenitor cells at three different sites: one within mitochondrial DNA, one within expressed nuclear DNA, and one within unexpressed nuclear DNA. We determined the degree of damage at each site via a quantitative polymerase chain reaction, which compares amplification of control, untreated DNA to that from cells exposed to the agent in question. We found that ECH and the related compound epibromohydrin preferentially target nuclear DNA relative to mitochondrial DNA, whereas DEB reacts similarly with the two genomes. Decreased reactivity of the mitochondrial genome could contribute to the reduced apoptotic potential of ECH relative to DEB. Additionally, formation of lesions by all agents occurred at comparable levels for unexpressed and expressed nuclear loci, suggesting that alkylation is unaffected by the degree of chromatin condensation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428380      PMCID: PMC2727856          DOI: 10.1016/j.mrfmmm.2009.02.004

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  60 in total

Review 1.  Repair of DNA damage in mitochondria.

Authors:  D E Sawyer; B Van Houten
Journal:  Mutat Res       Date:  1999-07-30       Impact factor: 2.433

2.  The nucleus's revolving door.

Authors:  E Pennisi
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

3.  Dynamics of mitochondrial DNA evolution in animals: amplification and sequencing with conserved primers.

Authors:  T D Kocher; W K Thomas; A Meyer; S V Edwards; S Pääbo; F X Villablanca; A C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 4.  Analysis of potential cancer biomarkers in mitochondrial DNA.

Authors:  John P Jakupciak; Gabriel D Dakubo; Samantha Maragh; Ryan L Parr
Journal:  Curr Opin Mol Ther       Date:  2006-12

5.  Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.

Authors:  Shanbao Cai; Yi Xu; Ryan J Cooper; Michael J Ferkowicz; Jennifer R Hartwell; Karen E Pollok; Mark R Kelley
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus.

Authors:  M D Litt; M Simpson; M Gaszner; C D Allis; G Felsenfeld
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

8.  Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases.

Authors:  S D Michels; R W McKenna; D C Arthur; R D Brunning
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

9.  Cancer mortality among workers at a butadiene production facility.

Authors:  B J Divine; J K Wendt; C M Hartman
Journal:  IARC Sci Publ       Date:  1993

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.